Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Beccia, Mario
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction	Terminated	3	535	Europe, Canada, Japan, US, RoW	BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo	Remedy Pharmaceuticals, Inc.	Brain Edema, Stroke, Acute	08/23	08/23
READAPT, NCT05476081: A REAl-life Study on Short-term DAPT in Patients With Ischemic Stroke or TIA	Completed	N/A	2239	Europe	Aspirin, B01AC06, acetylsalicylic acid, Clopidogrel, B01AC04, Ticagrelor, B01AC24	University of L'Aquila	Ischemic Stroke, TIA	02/23	05/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Beccia, Mario
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction	Terminated	3	535	Europe, Canada, Japan, US, RoW	BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo	Remedy Pharmaceuticals, Inc.	Brain Edema, Stroke, Acute	08/23	08/23
READAPT, NCT05476081: A REAl-life Study on Short-term DAPT in Patients With Ischemic Stroke or TIA	Completed	N/A	2239	Europe	Aspirin, B01AC06, acetylsalicylic acid, Clopidogrel, B01AC04, Ticagrelor, B01AC24	University of L'Aquila	Ischemic Stroke, TIA	02/23	05/23